|

PF-07850327, ARV-471, vepdegestrant Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Pfizer1

Indications

  • Locally Advanced or Metastatic Castration-resistant Prostate Cancer1
  • Locally Advanced or Metastatic ER+ HER2- Breast Cancer1
  • Locally Advanced or Metastatic Non-small Cell Lung Cancer1
  • Lung Cancer1
  • Breast Cancer1

Scottsdale, Arizona1 trial

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

HonorHealth

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.